mAb Development

Jul 29, 2015
A broad indication for GSK’s investigational mAb mepolizumab, coupled with an upcoming FDA decision date, could give the manufacturer a competitive advantage in the biologic asthma market.
Jul 21, 2015
By BioPharm International Editors
The $19.7 million contract will assist Emergent with the development of cGMP lots of three Ebola mAbs.
Jul 07, 2015
By BioPharm International Editors
Catalent’s licensing of Excelimmune’s antibody combination therapy platform can enable more consistent, cost effective production of antibody combinations.
Jun 22, 2015
Monoclonal antibodies can facilitate the entry of radiopharmaceuticals into cells, David Scheinberg said at BIO 2015.
Jun 10, 2015
BioPharm International
An FDA advisory panel voted 13-3 in favor of approval of Sanofi and Regeneron Pharmaceuticals' cholesterol-homeostasis therapy Praluent (alirocumab).
Mar 24, 2015
BioPharm International
Clinical trial results suggest that monoclonal antibodies targeting the function of proinflammatory cytokine IL-17A in psoriasis may be significantly superior to other treatments.
Mar 01, 2015
BioPharm International
Large-scale implementation of Protein A chromatography offers several challenges.
Feb 20, 2015
BioPharm International
MedImmune will provide funds and access to monoclonal antibodies to seven postdoctoral associates for the creation of protein measurement and characterization tools.
Feb 17, 2015
BioPharm International
Antibodies in research should be standardized and categorized using a barcode-like classification system, according to research published in Nature.
Jan 26, 2015
BioPharm International
The potential blockbuster treatment targets a protein involved in cholesterol homeostasis.
lorem ipsum